KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Capital Expenditures (2016 - 2025)

Petmed Express' Capital Expenditures history spans 16 years, with the latest figure at -$21000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 102.7% year-over-year to -$21000.0; the TTM value through Dec 2025 reached $3.3 million, up 22.57%, while the annual FY2025 figure was $2.2 million, N/A changed from the prior year.
  • Capital Expenditures reached -$21000.0 in Q4 2025 per PETS's latest filing, down from $2.6 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $2.6 million in Q3 2025 to a low of -$3.3 million in Q1 2023.
  • Average Capital Expenditures over 5 years is $442157.9, with a median of $683000.0 recorded in 2024.
  • Peak YoY movement for Capital Expenditures: skyrocketed 237.76% in 2022, then crashed 784.98% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at $294000.0 in 2021, then surged by 237.76% to $993000.0 in 2022, then tumbled by 315.21% to -$2.1 million in 2023, then surged by 136.36% to $777000.0 in 2024, then plummeted by 102.7% to -$21000.0 in 2025.
  • Per Business Quant, the three most recent readings for PETS's Capital Expenditures are -$21000.0 (Q4 2025), $2.6 million (Q3 2025), and $1.3 million (Q2 2025).